9 Months in, Stem Cell Therapy for Spinal Cord Injury Continues to Improve Paralyzed Patient’s Life

Asterias Biotherapeutics is a biotechnology company, which is dedicated to regenerative medicine. Recently they have launched a new medicine AST-OPC1 that offers embryonic stem cell based treatment for patients with spinal cord injuries. The medicine was under trail for a while and now it has been declared completely safe and highly effective for patients with […]



Asterias Biotherapeutics is a biotechnology company, which is dedicated to regenerative medicine. Recently they have launched a new medicine AST-OPC1 that offers embryonic stem cell based treatment for patients with spinal cord injuries. The medicine was under trail for a while and now it has been declared completely safe and highly effective for patients with spinal cord diseases.

strotherinvestments
US

Categories